Your browser doesn't support javascript.
loading
Targeting the survival kinase DYRK1B: A novel approach to overcome radiotherapy-related treatment resistance.
Beckers, Claire; Vasilikos, Lazaros; Sanchez Fernandez, Alba; Moor, Lorena; Pruschy, Martin.
Afiliação
  • Beckers C; Laboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: claire.beckers@uzh.ch.
  • Vasilikos L; Laboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: lazaros.vasilikos@vvf.uzh.ch.
  • Sanchez Fernandez A; Laboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: alba.sanchez-fernandez@uzh.ch.
  • Moor L; Laboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: lmoor@student.ethz.ch.
  • Pruschy M; Laboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: martin.pruschy@uzh.ch.
Radiother Oncol ; 190: 110039, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38040123
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article